GMC Srinagar hosts inaugural Luminal Malignancy Day

SRINAGAR — In a significant leap forward in the fight against gastrointestinal cancers, the Department of Minimal Access and General Surgery at Government Medical College Srinagar spearheaded the inaugural Luminal Malignancy Day on Thursday.

Collaborating with the Department of Radiation and Medical Oncology, this milestone event underscored the institution’s commitment to advancing treatment options and raising awareness for luminal malignancies.

Led by the esteemed Professor Iqbal Saleem Mir, Head of the Department of Surgery, the day showcased a series of groundbreaking surgeries utilizing cutting-edge laparoscopic techniques. These procedures, targeting various gastrointestinal malignancies, highlighted the faculty’s expertise and dedication to providing minimally invasive yet highly effective treatment options.

The Luminal Malignancy Day served as a nexus for interdisciplinary collaboration, uniting experts from surgery, radiation oncology, medical oncology, and the Department of Anaesthesia. This collaborative effort ensures patients receive comprehensive care tailored to their individual needs, from diagnosis to treatment and beyond.

Attendees witnessed live demonstrations of laparoscopic procedures, offering firsthand insight into the precision and innovation driving modern surgical techniques. Professor Iqbal Saleem Mir expressed gratitude to all faculty members, staff, and participants whose collective efforts propelled the Luminal Malignancy Day to resounding success.

Principal of Government Medical College Srinagar, Professor Iffat Hassan Shah, hailed the initiative as a significant milestone in addressing the challenges posed by gastrointestinal cancers. She emphasized the importance of collaboration across specialities in providing comprehensive and state-of-the-art care to patients.

Government Medical College Srinagar reaffirmed its commitment to leading the charge against cancer, aiming to enhance outcomes and quality of life for those affected by luminal malignancies. With an unwavering dedication to medical innovation, the institution stands as a beacon of hope for individuals and families confronting cancer.